|  Help  |  About  |  Contact Us

Publication : Mouse genetics reveals Barttin as a genetic modifier of Joubert syndrome.

First Author  Ramsbottom SA Year  2020
Journal  Proc Natl Acad Sci U S A Volume  117
Issue  2 Pages  1113-1118
PubMed ID  31879347 Mgi Jnum  J:283231
Mgi Id  MGI:6386259 Doi  10.1073/pnas.1912602117
Citation  Ramsbottom SA, et al. (2020) Mouse genetics reveals Barttin as a genetic modifier of Joubert syndrome. Proc Natl Acad Sci U S A 117(2):1113-1118
abstractText  Genetic and phenotypic heterogeneity and the lack of sufficiently large patient cohorts pose a significant challenge to understanding genetic associations in rare disease. Here we identify Bsnd (alias Barttin) as a genetic modifier of cystic kidney disease in Joubert syndrome, using a Cep290-deficient mouse model to recapitulate the phenotypic variability observed in patients by mixing genetic backgrounds in a controlled manner and performing genome-wide analysis of these mice. Experimental down-regulation of Bsnd in the parental mouse strain phenocopied the severe cystic kidney phenotype. A common polymorphism within human BSND significantly associates with kidney disease severity in a patient cohort with CEP290 mutations. The striking phenotypic modifications we describe are a timely reminder of the value of mouse models and highlight the significant contribution of genetic background. Furthermore, if appropriately managed, this can be exploited as a powerful tool to elucidate mechanisms underlying human disease heterogeneity.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

4 Bio Entities

Trail: Publication

0 Expression